Last10K.com

American Cryostem Corp (CRYO) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

American Cryostem Corp

HISTORY TOOLS
CIK: 1918661 Ticker: CRYO
Cover - shares
6 Months Ended
Mar. 31, 2022
May 23, 2022
Cover [Abstract]  
Document Type10-Q 
Amendment Flagfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Document Period End DateMar. 31, 2022 
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2022 
Current Fiscal Year End Date--09-30 
Entity File Number000-54672 
Entity Registrant NameAmerican CryoStem Corporation 
Entity Central Index Key0001468679 
Entity Tax Identification Number26-4574088 
Entity Incorporation, State or Country CodeNV 
Entity Address, Address Line One1 Meridian Road 
Entity Address, City or TownEatontown 
Entity Address, State or ProvinceNJ 
Entity Address, Postal Zip Code07724 
City Area Code(732) 
Local Phone Number747-1007 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 43,692,922

View differences made from one quarter to another to evaluate American Cryostem Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Cryostem Corp.

Continue

Assess how American Cryostem Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Cryostem Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Consolidated Balance Sheets (Unaudited)
Consolidated Balance Sheets (Unaudited) (Parenthetical)
Consolidated Statements Of Cash Flows (Unaudited)
Consolidated Statements Of Changes In Shareholders' Deficit (Equity) (Unaudited)
Consolidated Statements Of Operations (Unaudited)
Common Stock Transactions
Common Stock Transactions (Details Narrative)
Concentration Of Credit
Debt
Debt (Details)
Debt (Tables)
Fair Values Of Financial Instruments
Fixed Assets
Fixed Assets (Details Narrative)
Fixed Assets (Details)
Fixed Assets (Tables)
Going Concern
Going Concern (Details Narrative)
Investments
Leases
Leases (Details Narrative)
Leases (Details)
Leases (Tables)
Loss Per Share
Loss Per Share (Details Narrative)
Loss Per Share (Details)
Loss Per Share (Tables)
Option Issuances
Option Issuances (Details 2)
Option Issuances (Details Narrative)
Option Issuances (Details)
Option Issuances (Tables)
Organization Of The Company And Significant Accounting Policies
Organization Of The Company And Significant Accounting Policies (Details Narrative)
Organization Of The Company And Significant Accounting Policies (Details)
Organization Of The Company And Significant Accounting Policies (Policies)
Organization Of The Company And Significant Accounting Policies (Tables)
Patent &Amp; Patents Filings
Patent &Amp; Patents Filings (Details Narrative)
Patent &Amp; Patents Filings (Tables)
Related Party Transactions
Related Party Transactions (Details Narrative)
Revenue Recognition
Schedule Of Finance Lease Obligation (Details)
Schedule Of Operating Lease (Details)
Schedule Of Operating Lease Obligation (Details)
Schedule Of Patent Amortization (Details)
Subsequent Events

Material Contracts, Statements, Certifications & more

American Cryostem Corp provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Ticker: CRYO
CIK: 1468679
Form Type: 10-Q Quarterly Report
Accession Number: 0001019056-22-000403
Submitted to the SEC: Mon May 23 2022 4:02:15 PM EST
Accepted by the SEC: Mon May 23 2022
Period: Thursday, March 31, 2022
Industry: Health And Allied

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/cryo/0001019056-22-000403.htm